SCHEMBL1127133

SCHEMBL1127133

CN(C)CCN(C)Cc1ccc(N)nc1.COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3nc(CN(C)C)c[nH]3)c3nccnc23)c1F

nearest known ligand 0.61

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 20/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1126457 0.88 FGFR3 (0.74) FGFR3
SCHEMBL1126541 0.87 FGFR3 (0.64) FGFR3
SCHEMBL4318689 0.85 FGFR3 (0.54) FGFR3
SCHEMBL3346280 0.85 FGFR3 (0.66) FGFR3
SCHEMBL1126391 0.83 FGFR3 (0.75) FGFR3
SCHEMBL29564243 0.83 FGFR3 (0.72) FGFR3
SCHEMBL1126312 0.83 FGFR3 (0.72) FGFR3
SCHEMBL1126507 0.83 FGFR3 (0.72) FGFR3
SCHEMBL3347253 0.82 FGFR3 (0.63) FGFR3
SCHEMBL1126389 0.82 FGFR3 (0.69) FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282995-A1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS Novartis AG (CH) 2011-02-16 EP claimed